DAX19.323 +0,9%ESt504.789 +0,7%MSCIW3.766 +0,3%Dow44.297 +1,0%Nas19.004 +0,2%Bitcoin94.540 -0,5%Euro1,0417 -0,6%Öl75,28 +1,2%Gold2.709 ±0,0%

1 Aktie gratis Trading Krypto kaufen^* ETF-Sparplan

Evofem Biosciences Aktie

NeuKaufen Verkaufen

Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!

Bei einem anderen Broker handeln Smartphone

Smartphone

WKNA3DL69

ISINUS30048L2034

SymbolEVFM

Werbung

Evofem Biosciences Aktien News

Sortieren:Datum Meistgelesen

14.11.24PR NewswireEvofem Biosciences Announces Financial Results for the Third Quarter of 2024

11.06.24PR NewswireEvofem Announces Issuance of New U.S. Patent Covering Phexxi Composition of Matter

18.04.24PR NewswireEvofem Strengthens Phexxi Intellectual Property with New Composition of Matter Patent From USPTO

20.03.24PR NewswireEvofem Negotiates Improved Rebate for Hormone-Free "In the Moment" Contraceptive PHEXXI with Medi-Cal

01.02.24PR NewswireEvofem Biosciences Announces Strong Preliminary Results, Record Phexxi Net Sales for Fiscal 2023

14.11.23PR NewswireEvofem Biosciences Announces Financial Results for the Third Quarter of 2023

24.10.23PR NewswireEvofem Biosciences Announces Preliminary Results for the Third Quarter of 2023

13.10.23PR NewswireEvofem to Participate in the Virtual Investor Ask the CEO Conference

27.09.23PR NewswireEvofem Announces Padagis Will Not Seek FDA Approval to Market a Generic Version of Phexxi® Until Evofem's Phexxi Patents Expire

11.09.23PR NewswireEvofem Biosciences Successfully Amends S.P.A. with Institutional Investor

22.08.23PR NewswireEvofem Biosciences Signs Non-Binding Letter of Intent to Enable Listing on a National Stock Exchange

14.08.23PR NewswireEvofem Biosciences Announces Financial Results for the Second Quarter of 2023

06.07.23PR NewswireEvofem to Participate in the Virtual Investor Summer Spotlight Series

01.06.23PR NewswireEvofem Biosciences Announces Strong Preliminary Results for the First Quarter of 2023

17.05.23PR NewswireEvofem Biosciences Announces 1-for-125 Reverse Stock Split

28.04.23PR NewswireEvofem Biosciences Reports Year-End 2022 Financial Results and Provides Corporate Update

14.04.23PR NewswireEvofem Appoints Ivy Zhang as Chief Financial Officer and Secretary

21.03.23PR NewswireEvofem Biosciences Announces Cost Reduction Measures

09.03.23PR NewswireEvofem Biosciences Appoints Interim Chief Financial Officer

27.02.23PR NewswireEvofem Biosciences Announces FDA Orange Book Listing of Two Additional U.S. Patents for Phexxi

09.01.23PR NewswireMultiple New Insurance Wins Expand and Improve Access to Phexxi® for Millions of Women

16.09.22PR NewswireLarge Commercial Payer Adds Phexxi® to Formulary for Standard Plans Nationwide

16.09.22PR NewswireEvofem Announces Successful Debt Restructuring

11.08.22PR NewswireEvofem Biosciences to Host Investor Call on Thursday, August 11, 2022

06.08.22finanzen.netEvofem Biosciences: So viel setzte das Unternehmen zuletzt um

04.08.22PR NewswireEvofem Biosciences Announces Strong Second Quarter 2022 Financial Results and Affirms 2022 Guidance

04.08.22finanzen.netAusblick: Evofem Biosciences stellt Ergebnisse des abgelaufenen Quartals vor

29.07.22PR NewswireEvofem Biosciences Commends Tri-Agencies for Clarifying that Contraceptives Must be Covered at No Cost to Individuals

21.07.22PR NewswireEvofem Partners with a360 Media to Support Phexxi® Prescription Growth

30.06.22PR NewswireEvofem Strengthens Phexxi® Intellectual Property with New Composition of Matter Patent From USPTO

Evofem Biosciences News

Evofem Biosciences News: auf dieser Seite finden Sie alle Evofem Biosciences News und Nachrichten zur Evofem Biosciences Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Evofem Biosciences News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Evofem Biosciences News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.